FDA and advisory panels mostly on the same page

Share this article:
FDA and advisory panels mostly on the same page
FDA and advisory panels mostly on the same page

A McKinsey Center for Government analysis shows that in the period 2001-2010, FDA approved 88% of NDAs and BLAs that were supported by advisory committees and did not approve 86% of those not endorsed by the committees.

“When the approval decision made by FDA differed from the recommendation of the advisory committee, FDA did so at the same rate regardless of whether the panel endorsed approval,” the report says.

The McKinsey team found that in 87% of committee meetings, the result was a clear “yes” or “no” vote, possibly due to committee members' expertise in their field that allows them to readily address areas of uncertainty in an application. Another possible explanation, the report says, is a “herding” effect in which influential members convince others of their point of view.

McKinsey says its results have important implications for companies preparing for potential advisory committee meetings. “We believe that the use of bodies akin to advisory committees could be considerably expanded by industry,” the report says.

“Companies currently use mock advisory panels to help rehearse and prepare for advisory committee meetings,” it notes. “Given the sensitivity and specificity of the approach, companies may be better served by incorporating the approach into decision-making, not merely preparation.”

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.